{"title": "La soluci\u00f3n a la bronquiolitis est\u00e1 cada vez m\u00e1s cerca", "author": "The Conversation", "url": "https://theobjective.com/sociedad/2022-11-27/bronquiolitis-solucion/", "hostname": "theobjective.com", "description": "Desde octubre de 2022, los casos de bronquiolitis en ni\u00f1os peque\u00f1os han aumentado r\u00e1pidamente a nivel mundial, causando alarma social y preocupaci\u00f3n. Los", "sitename": "The Objective", "date": "2022-11-27", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "La soluci\u00f3n a la bronquiolitis est\u00e1 cada vez m\u00e1s cerca\nEste tipo de bronquiolitis est\u00e1 causado principalmente por el virus respiratorio sincitial, un virus respiratorio com\u00fan que generalmente causa s\u00edntomas leves\nDesde octubre de 2022, los casos de\n[bronquiolitis en ni\u00f1os](https://theobjective.com/sociedad/2022-11-25/farmaco-bronquiolitis/) peque\u00f1os han aumentado r\u00e1pidamente a nivel mundial, causando alarma social y preocupaci\u00f3n. Los Centros para el Control y Prevenci\u00f3n de Enfermedades de Estados Unidos, Europa, y otras regiones ya est\u00e1n vigilando con cierta inquietud esta epidemia.\nEste tipo de bronquiolitis est\u00e1 causado principalmente por\n[el virus respiratorio sincitial](https://theconversation.com/el-virus-respiratorio-que-mas-preocupa-a-los-pediatras-y-no-es-el-coronavirus-132562) (VRS). Se trata de un virus respiratorio com\u00fan que generalmente causa s\u00edntomas leves similares a los del resfriado. La mayor\u00eda de las personas adultas se recuperan en unos pocos d\u00edas pero, con relativa frecuencia, causa infecciones graves en beb\u00e9s.\nEn estas infecciones, las v\u00edas respiratorias peque\u00f1as (bronquiolos) se inflaman y se obstruyen con mucosidad, dificultando la respiraci\u00f3n. Esto da lugar a multitud de visitas pedi\u00e1tricas en atenci\u00f3n primaria y, en los casos m\u00e1s extremos, a hospitalizaciones.\nEl VRS se est\u00e1 comportando de forma an\u00f3mala\nLas epidemias de VRS han sido muy regulares antes de la\n[covid-19](/etiqueta/coronavirus), empezando todos los a\u00f1os a finales de oto\u00f1o o en invierno y desapareciendo durante los meses de primavera/verano. Sin embargo, las medidas que ayudaron a mantenernos a salvo de la covid-19 durante los \u00faltimos dos a\u00f1os y medio (cierres, distanciamiento social, uso de mascarillas, lavado de manos) tambi\u00e9n [limitaron la propagaci\u00f3n de otros virus](https://www.nature.com/articles/s41579-022-00807-9), incluido el VRS.\nPor esa raz\u00f3n, durante las\n[temporadas de 2020 y 2021](https://www.mdpi.com/2036-7449/14/4/59) se produjo un repentino descenso de los casos y las hospitalizaciones por VRS. Sin embargo, este a\u00f1o, la temporada ha comenzado antes de lo habitual. Y aunque el aumento de casos ha sido m\u00e1s evidente desde finales de octubre, el VRS empez\u00f3 a detectarse incluso durante la primavera.\nAdem\u00e1s, el virus se est\u00e1 propagando m\u00e1s r\u00e1pidamente y causando\n[m\u00e1s hospitalizaciones](https://www.cdc.gov/rsv/research/rsv-net/dashboard.html) de lo habitual, lo que est\u00e1 poniendo a prueba el sistema sanitario en [varios pa\u00edses](https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-week-46.pdf). En otros [pa\u00edses](https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/VIGILANCIA-CENTINELA-DE-INFECCION-RESPIRATORIA-AGUDA.aspx), en cambio, todav\u00eda no se ha observado un aumento en las hospitalizaciones con respecto a temporadas anteriores a la pandemia, aunque es pronto para sacar conclusiones.\nEsto no es del todo inesperado, ya que, a medida que los ni\u00f1os vuelven a la guarder\u00eda o la escuela, en las que ya no se siguen las medidas preventivas vigentes durante pandemia, los virus, incluidos el VRS, vuelven de nuevo.\nLa teor\u00eda del d\u00e9ficit inmunitario\nPero \u00bfpor qu\u00e9 el VRS se trasmite m\u00e1s r\u00e1pido y causa m\u00e1s infecciones graves este a\u00f1o? Tanto los ni\u00f1os como las madres desarrollan defensas frente a los virus cuando entran en contacto con ellos. Pero durante la pandemia de la covid-19, la poblaci\u00f3n en general tuvo pocas oportunidades de infectarse con el VRS o cualquier otro virus, por lo que no adquirieron inmunidad frente a ellos.\nEste\n[d\u00e9ficit inmunitario](https://www.sciencedirect.com/science/article/pii/S2666991921001123?via%3Dihub) podr\u00eda explicar por qu\u00e9 el VRS vuelve con m\u00e1s fuerza cuando han desaparecido las medidas preventivas encaminadas a contener la covid-19. Se nota especialmente en los reci\u00e9n nacidos, puesto que las madres transfieren sus defensas al feto a trav\u00e9s de la placenta y, despu\u00e9s del nacimiento, a trav\u00e9s de la leche. As\u00ed, los reci\u00e9n nacidos est\u00e1n protegidos frente al VRS durante los primeros meses de vida siempre y cuando sus madres lo est\u00e9n.\nLa soluci\u00f3n a la bronquiolitis por VRS est\u00e1 cada vez m\u00e1s cerca\nActualmente existe un medicamento, aprobado a finales del siglo pasado, que puede ayudar a proteger a algunos beb\u00e9s que tienen alto riesgo de enfermar gravemente por el VRS. Se trata de un anticuerpo llamado palivizumab que se administra en forma de inyecciones mensuales a los beb\u00e9s prematuros y a ni\u00f1os peque\u00f1os con ciertas afecciones del coraz\u00f3n y los pulmones. Pero este f\u00e1rmaco es caro y de eficacia limitada, por lo que se administra s\u00f3lo en casos muy concretos.\nEn los \u00faltimos a\u00f1os, gracias al trabajo de multitud de laboratorios de todo el mundo, el desarrollo de nuevos tratamientos y vacunas frente al VRS ha experimentado grandes avances. Actualmente, existen alrededor de\n[39 aproximaciones](https://media.path.org/documents/RSV_Vaccine_and_mAb_Snapshot_September_9_2022.pdf?_gl=1*1x8da00*_ga*MTY5NTgzMzc4My4xNjY5MjEyMTI2*_ga_YBSE7ZKDQM*MTY2OTIxMjEyNi4xLjAuMTY2OTIxMjEyNi4wLjAuMA..) en distintas fases de ensayos cl\u00ednicos.\nUna de las m\u00e1s prometedoras es el anticuerpo\n[nirsevimab](https://pubmed.ncbi.nlm.nih.gov/35235726/), [aprobado](https://www.sanofi.com/en/media-room/press-releases/2022/2022-09-16-06-00-00-2517378) hace poco por la Agencia Europea del Medicamento. Este medicamento evita que el virus entre en nuestras c\u00e9lulas. La principal ventaja de nirsevimab respecto a palivizumab es que una \u00fanica inyecci\u00f3n intramuscular protege a los ni\u00f1os neonatos y lactantes durante su primera temporada del VRS.\nVacunar a las madres\nCon todo, lo ideal para prevenir las bronquiolitis por VRS ser\u00eda disponer\n[de una vacuna](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext). Los ni\u00f1os peque\u00f1os, sin embargo, no tienen bien desarrollado el sistema inmune y responden mal a la vacunaci\u00f3n. Por eso para los ni\u00f1os menores de 6 meses, lo que se recomienda es la inmunizaci\u00f3n pasiva, es decir, la administraci\u00f3n de anticuerpos.\nUna alternativa interesante es la vacunaci\u00f3n de las madres. En este caso, los reci\u00e9n nacidos, tal como se ha explicado antes, se ver\u00edan beneficiados por la transferencia de anticuerpos de la madre a trav\u00e9s de la placenta y/o la lactancia.\nLas vacunas basadas en subunidades (partes del virus, principalmente la denominada prote\u00edna F) son las que est\u00e1n m\u00e1s avanzadas para su uso en\n[embarazadas](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext). Recientemente, Pfizer ha comunicado una alta eficacia y seguridad de su vacuna en madres embarazadas para prevenir la enfermedad grave de las v\u00edas respiratorias debida VRS.\nEn el caso de los ni\u00f1os mayores de 6 meses, una de las opciones que se contempla es su vacunaci\u00f3n mediante la administraci\u00f3n intranasal de\n[virus completos atenuados](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924568/), es decir, que no causan enfermedad. Estas vacunas est\u00e1n en las \u00faltimas fases de ensayos cl\u00ednicos.\nEn definitiva, cada vez estamos m\u00e1s cerca de tener las\n[herramientas adecuadas](https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/) para prevenir las temidas bronquiolitis causadas por el VRS.\n***\nEste art\u00edculo fue publicado originalmente en\n[The Conversation](https://theconversation.com). Lea el [original](https://theconversation.com/bronquiolitis-por-el-virus-respiratorio-sincitial-como-esta-la-situacion-195231).", "language": null, "image": "https://theobjective.com/wp-content/uploads/2022/11/bebe-1.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/sociedad/", "https://theobjective.com/autor/", "", "https://theobjective.com/autor/", "", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F&text=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca&via=TheObjective_es", "//web.whatsapp.com/send?text=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F&title=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F&text=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca%20The Objective", "/cdn-cgi/l/email-protection#49763a3c2b232c2a3d741d2c6c7b79393c2c2d2c6c7b7920273d2c3b2c3a283b6767676f2b262d307405286c7b793a26253c2a206c0a7a6c0b7a276c7b79286c7b7925286c7b792b3b2627383c202625203d203a6c7b792c3a3d6c0a7a6c08786c7b792a282d286c7b793f2c336c7b79246c0a7a6c08783a6c7b792a2c3b2a286c7b79213d3d393a6c7a086c7b0f6c7b0f3d212c262b232c2a3d203f2c672a26246c7b0f3a262a202c2d282d6c7b0f7b797b7b647878647b7e6c7b0f2b3b2627383c202625203d203a643a26253c2a2026276c7b0f", "https://theobjective.com/sociedad/2022-11-25/farmaco-bronquiolitis/", "https://theconversation.com/el-virus-respiratorio-que-mas-preocupa-a-los-pediatras-y-no-es-el-coronavirus-132562", "/etiqueta/coronavirus", "https://www.nature.com/articles/s41579-022-00807-9", "https://www.mdpi.com/2036-7449/14/4/59", "https://www.cdc.gov/rsv/research/rsv-net/dashboard.html", "https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-week-46.pdf", "https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/VIGILANCIA-CENTINELA-DE-INFECCION-RESPIRATORIA-AGUDA.aspx", "https://theobjective.com/sociedad/2022-11-25/farmaco-bronquiolitis/", "https://theobjective.com/sociedad/2022-11-25/farmaco-bronquiolitis/", "https://theobjective.com/sociedad/2022-11-21/bronquiolitis-ninos-motivos/", "https://theobjective.com/sociedad/2022-11-21/bronquiolitis-ninos-motivos/", "https://www.sciencedirect.com/science/article/pii/S2666991921001123?via%3Dihub", "https://media.path.org/documents/RSV_Vaccine_and_mAb_Snapshot_September_9_2022.pdf?_gl=1*1x8da00*_ga*MTY5NTgzMzc4My4xNjY5MjEyMTI2*_ga_YBSE7ZKDQM*MTY2OTIxMjEyNi4xLjAuMTY2OTIxMjEyNi4wLjAuMA..", "https://theobjective.com/further/sociedad/2021-07-17/gripe-y-bronquiolitis-evitar-la-covid-19-un-arma-de-doble-filo/", "https://theobjective.com/further/sociedad/2021-07-17/gripe-y-bronquiolitis-evitar-la-covid-19-un-arma-de-doble-filo/", "https://pubmed.ncbi.nlm.nih.gov/35235726/", "https://www.sanofi.com/en/media-room/press-releases/2022/2022-09-16-06-00-00-2517378", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924568/", "https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/", "https://theconversation.com", "https://theconversation.com/bronquiolitis-por-el-virus-respiratorio-sincitial-como-esta-la-situacion-195231", "https://theobjective.com/autor/", "", "https://theobjective.com/autor/", "", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F&text=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca&via=TheObjective_es", "//web.whatsapp.com/send?text=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F&title=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-11-27%2Fbronquiolitis-solucion%2F&text=La%20soluci%C3%B3n%20a%20la%20bronquiolitis%20est%C3%A1%20cada%20vez%20m%C3%A1s%20cerca%20The Objective", "/cdn-cgi/l/email-protection#58672b2d3a323d3b2c650c3d7d6a68282d3d3c3d7d6a6831362c3d2a3d2b392a7676767e3a373c216514397d6a682b37342d3b317d1b6b7d1a6b367d6a68397d6a6834397d6a683a2a3736292d313734312c312b7d6a683d2b2c7d1b6b7d19697d6a683b393c397d6a682e3d227d6a68357d1b6b7d19692b7d6a683b3d2a3b397d6a68302c2c282b7d6b197d6a1e7d6a1e2c303d373a323d3b2c312e3d763b37357d6a1e2b373b313d3c393c7d6a1e6a686a6a756969756a6f7d6a1e3a2a3736292d313734312c312b752b37342d3b3137367d6a1e", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/enfermedades/", "https://theobjective.com/etiqueta/investigacion/", "https://theobjective.com/etiqueta/medicina/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/sociedad/2022-12-01/ojo-seco-tratamiento/", "https://theobjective.com/sociedad/2022-12-01/ojo-seco-tratamiento/", "https://theobjective.com/sociedad/2022-12-04/mundo-dinosaurios-extincion/", "https://theobjective.com/sociedad/2022-12-04/mundo-dinosaurios-extincion/", "https://theobjective.com/sociedad/2022-12-04/mundo-dinosaurios-extincion/?comentarios=1", "https://theobjective.com/sociedad/2022-12-01/estres-pandemia-adolescentes/", "https://theobjective.com/sociedad/2022-12-01/estres-pandemia-adolescentes/", "https://theobjective.com/espana/politica/2022-12-03/espana-ranking-tabaco/", "https://theobjective.com/espana/politica/2022-12-03/espana-ranking-tabaco/", "https://theobjective.com/sociedad/2022-12-02/gusanos-marinos-gigantes/", "https://theobjective.com/sociedad/2022-12-02/senior-espanol-emprendedor/", "https://theobjective.com/sociedad/2022-12-04/nina-hospital-corazon-la-paz/", "https://theobjective.com/sociedad/2022-12-01/terapia-vih-bebes-gestacion/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}